Natera, Inc. ($NTRA)
Filing Information
| Accession Number | 0002010019-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 4, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
23,301
Total Value
$648,693.81
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Feb 27, 2026 | Grant/Award | 10,051 | โ | โ | 147,898 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Mar 2, 2026 | Exercise/Conversion | 5,125 | $9.59 | $49,148.75 | 153,023 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Mar 2, 2026 | Sale | 931 | $198.83 | $185,114.27 | 152,092 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Mar 2, 2026 | Sale | 1,594 | $200.11 | $318,971.04 | 150,498 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Mar 2, 2026 | Sale | 475 | $200.97 | $95,459.75 | 150,023 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Stock Option (right to buy) | Derivative | Mar 2, 2026 | Exercise/Conversion | 5,125 | $0.00 | $0.00 | 0 | Direct | โ | View Details |